ADX-102 1% Topical Dermal Cream (reproxalap) ( DrugBank: Reproxalap )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
160	先天性魚鱗癬	1

160. 先天性魚鱗癬

臨床試験数 : 42 / 薬物数 : 71 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 112

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03445650 (ClinicalTrials.gov)	July 18, 2018	14/2/2018	RESET Trial - Part 1 (Followed by Reset Trial - Part 2) - A Phase 3 Trial in Subjects With Sjögren-L ...	A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Trial to Evaluate the Safety ...	Sjogren-Larsson Syndrome	Drug: ADX-102 1% Topical Dermal Cream (reproxalap);Drug: Vehicle of ADX-102 Topical Dermal Cream	Aldeyra Therapeutics, Inc.	NULL	Completed	3 Years	N/A	All	11	Phase 3	United States

First Previous1Next Last